bullish
Wuxi Biologics Placement: Another Pre-Lockup Placement but Past Deals Have Done Well
542 Views31 Mar 2020 18:52
Wuxi Biologics Holdings is looking to raise up to US$513m by selling 3.2% of Wuxi Biologics (Cayman) Inc (2269 HK). This will be eight placement by...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Wuxi Biologics Placement - This Time It's Different29 Jun 2020
- Wuxi Biologics Placement - Biggest Deal Size at Launch, Well Ahead of Lock-Up Expiry20 May 2020
- China Health Care - Allocation Boom: Wuxi Biologics/Jinyu Bio-Tech/Hangzhou Tigermed Top Picks13 May 2020
- Wuxi Biologics Placement: Almost All of the past Deals Have Done Well, Would Bid near the Bottom End09 Jan 2020
- Wuxi Biologics Placement: A Larger Deal but Performance Track Record Weighs31 Oct 2019
- Wuxi Biologics Placement: Past Deal Did Well Despite Sell-Down Overhang18 Jun 2019
x